AAAAAA

   
Results: 1-8 |
Results: 8
Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks
Authors: Barbelivien, A Nyman, L Haapalinna, A Sirvio, J
Citation: A. Barbelivien et al., Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks, PHARM TOX, 88(6), 2001, pp. 304-312
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes
Authors: Hidestrand, M Oscarson, M Salonen, JS Nyman, L Pelkonen, O Turpeinen, M Ingelman-Sundberg, M
Citation: M. Hidestrand et al., CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes, DRUG META D, 29(11), 2001, pp. 1480-1484
CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline
Authors: Laine, K Anttila, M Nyman, L Wahlberg, A Bertilsson, L
Citation: K. Laine et al., CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline, EUR J CL PH, 57(2), 2001, pp. 137-142
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole
Authors: Kivisto, KT Wang, JS Backman, JT Nyman, L Taavitsainen, P Anttila, M Neuvonen, PJ
Citation: Kt. Kivisto et al., Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole, EUR J CL PH, 57(1), 2001, pp. 37-42
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats
Authors: Jolkkonen, J Kauppinen, R Nyman, L Haapalinna, A Sivenius, J
Citation: J. Jolkkonen et al., MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats, PHARM TOX, 87(5), 2000, pp. 242-245
Selegiline metabolism and cytochrome P450 enzymes: In vitro study in humanliver microsomes
Authors: Taavitsainen, P Anttila, M Nyman, L Karnani, H Salonen, JS Pelkonen, O
Citation: P. Taavitsainen et al., Selegiline metabolism and cytochrome P450 enzymes: In vitro study in humanliver microsomes, PHARM TOX, 86(5), 2000, pp. 215-221
Associations among oral estrogen use, free testosterone concentration, andlean body mass among postmenopausal women
Authors: Gower, BA Nyman, L
Citation: Ba. Gower et L. Nyman, Associations among oral estrogen use, free testosterone concentration, andlean body mass among postmenopausal women, J CLIN END, 85(12), 2000, pp. 4476-4480
Tamoxifen and toremifene concentrations in plasma are greatly decreased byrifampin
Authors: Kivisto, KT Villikka, K Nyman, L Anttila, M Neuvonen, PJ
Citation: Kt. Kivisto et al., Tamoxifen and toremifene concentrations in plasma are greatly decreased byrifampin, CLIN PHARM, 64(6), 1998, pp. 648-654
Risultati: 1-8 |